Irish Medicines Board in collaboration with the European Medicines Agency recommends an action plan to deal with the possible presence of endotoxins in Baxter peritoneal dialysis solutions

17 December 2010

The Irish Medicines Board in collaboration with the European Medicines Agency recommends an action plan to deal with the possible presence of endotoxins in Baxter peritoneal dialysis solutions.

Further information is available at the links below.

Press release on European Medicines Agency website

Q & A document on European Medicines Agency website